Page last updated: 2024-10-29

ifosfamide and Hyperglycemia, Postprandial

ifosfamide has been researched along with Hyperglycemia, Postprandial in 1 studies

Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.

Research Excerpts

ExcerptRelevanceReference
" Experiments in 214 DS carcinosarcoma bearing Wistar rats have shown that BA 1, at a dosage of only about 12 percent LD50 (150 mg kg) and negligible lethality (1."5.25[Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a ( Ardenne, M; Reitnauer, PG, 1975)
" Experiments in 214 DS carcinosarcoma bearing Wistar rats have shown that BA 1, at a dosage of only about 12 percent LD50 (150 mg kg) and negligible lethality (1."1.25[Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a ( Ardenne, M; Reitnauer, PG, 1975)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ardenne, M1
Reitnauer, PG1

Other Studies

1 other study available for ifosfamide and Hyperglycemia, Postprandial

ArticleYear
[Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a
    Arzneimittel-Forschung, 1975, Volume: 25, Issue:9

    Topics: Animals; Antineoplastic Agents; Carcinosarcoma; Cyclophosphamide; Drug Evaluation, Preclinical; Drug

1975